Introduction COVID-19 pandemic is thought to influence the natural history of immune
disorders, yet the knowledge on its effect on multiple sclerosis (MS) is unknown and not fully …

Background Multiple sclerosis (MS) is an immune-mediated disease that has been related to
several risk factors such as various viral infections. We carried out this study in order to …

Background The outbreak of coronavirus disease 2019 (COVID-19) has rapidly spread and
developed as a pandemic threatening global health. Patients with multiple sclerosis (MS) …

Background Given concerns over immune function, the decision whether to continue
disease modifying therapy (DMT) in multiple sclerosis (MS) patients during the COVID-19 …

Background Risk factors associated with coronavirus disease 2019 (COVID-19) severity in
patients with multiple sclerosis (MS) have been described. Recent improvements in …

Background In the current COVID-19 pandemic, Multiple Sclerosis (MS) patients represent a
population of particular interest as they might be at higher risk of COVID-19 infection and it's …

Background It has not previously been clarified if COVID-19 triggers disease activity and
increases the risk of hospitalisation with COVID-19 in patients with multiple sclerosis. We …

We read the study by Safavi et al.(2020) in a recent issue of Multiple Sclerosis and Related
Disorders with great interest. They reported a cross-sectional study among multiple sclerosis …

Background and purpose Long‐term outcome after COVID‐19 in patients with multiple
sclerosis (pwMS) has scarcely been studied, and controlled data are lacking. The objective …

Background and purpose Clinical outcomes of multiple sclerosis (MS) patients affected by
coronavirus disease 2019 (COVID‐19) have been thoroughly investigated, but a further …